Science
Mechanism of Action
Functions as a cell-communicating agent that specifically balances the Th17 immune pathway. It inhibits the expression of pro-inflammatory cytokines like IL-17, neutralizing the damaging effects of UV radiation and PM2.5 pollution before they can trigger collagen degradation.
Research
Clinical Evidence
High confidence3%
Key findings
- 01 In vivo clinical trials demonstrated a 34.5% overall improvement in periorbital wrinkles after 4 weeks of use.
- 02 Targeted measurements showed an 11% reduction in deep wrinkle depth and a 14% reduction in fine eyelid lines.
- 03 In vitro data confirms significant suppression of IL-17, the primary mediator of environmental skin inflammation.
Transparency
Dusting Analysis
As a specialized recombinant peptide, it is frequently used at concentrations below 1% in mass-market formulations for label claims. Moumoujus standards require at least 1% of the active solution to mirror clinical success in wrinkle reduction.
The Formula
Formulation
Stability
The capryloyl modification enhances lipophilicity and penetration. The molecule is stable at room temperature but is vulnerable to degradation by proteolytic enzymes and extreme thermal stress.
Synergies
- Hyaluronic Acid
- Niacinamide
- Non-proteolytic peptides
Conflicts
- Proteolytic enzymes (Papain, Bromelain)
- Strong oxidizing agents
- Extreme pH environments (<3.0 or >9.0)
Safety
Safety Profile
Human patch testing confirms it is non-irritating. Recognized by the EU Cosmetic Ingredient Glossary since 2022.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An advanced bio-mimetic peptide that offers a dual-action approach by soothing immune-related inflammation while clinically reducing wrinkle depth.
Related
Similar Ingredients
Finding similar ingredients…